List of Excipients in API ribociclib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ribociclib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | CELLULOSE, MICROCRYSTALLINE | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | CROSPOVIDONE | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | FERRIC OXIDE RED | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | FERROSOFERRIC OXIDE | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | HYDROXYPROPYL CELLULOSE | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | LECITHIN, SOYBEAN | 2036-04-14 |
| Novartis Pharmaceuticals Corporation | KISQALI | ribociclib | 0078-0860 | MAGNESIUM STEARATE | 2036-04-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ribociclib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ribociclib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
ribociclib drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ribociclib drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ribociclib drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ribociclib drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
ribociclib drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ribociclib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
ribociclib drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ribociclib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
ribociclib drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ribociclib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
ribociclib drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | ribociclib | 0078-0860 |
| >Company | >Ingredient | >NDC |
ribociclib drug variants not containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch